CHIEF COMPLAINT:
Lower urinary tract symptoms (LUTS).
PAST UROLOGICAL HISTORY:
Patient previously consulted at Groote Schuur Hospital in 2022 for LUTS. Diagnosed with benign prostatic hyperplasia (BPH). History of one episode of acute urinary retention requiring catheterisation in June 2023. No prior urological surgeries. Known history of prostate issues. Patient is a retired accountant.
HPI TODAY 01/11/2024:
Patient reports stable LUTS since the last consultation, with a slight increase in nocturia (waking 3-4 times per night compared to 2-3 times previously). Denies any new concerns, haematuria, dysuria, or fever. Patient confirms no current symptoms of infection.
Summary of recent renal ultrasound from Tygerberg Hospital dated 25/10/2024: Mild prostatic enlargement with no hydronephrosis. Post-void residual (PVR) of 85ml. I personally reviewed and independently interpreted the scan and concur with findings.
Lab results: Urine dipstick negative for blood, protein, and leukocytes. PSA total 3.8 ng/mL (previous 3.5 ng/mL six months ago). AUA symptom score: 17 (moderate symptoms). PVR volume post-void residual 85ml. PSA density 0.08 ng/mL/cc.
PMH, PSH, MEDS, ALLERGIES, SH, and FH:
- Past medical history: Hypertension, well-controlled on medication.
- Past surgical history: Appendectomy (1990).
- Medications: Ramipril 5mg daily, Tamsulosin 0.4mg daily, Multivitamin daily.
- Allergies: Penicillin (rash).
- Social history: Non-smoker, occasional social alcohol use (1-2 units per week). Lives with spouse in own home. Retired accountant.
- Family history: Father had BPH. No family history of urological cancers or renal disease.
PHYSICAL EXAMINATION:
General appearance: Alert and oriented, appears comfortable and in no acute distress.
Urological exam findings: DRE findings: Prostate enlarged, smooth, firm, non-tender, estimated 40-50g. No palpable nodules. Scrotal exam normal. No palpable bladder.
ASSESSMENT AND PLAN:
68-year-old male presenting with LUTS secondary to BPH, stable on treatment with a slight worsening of nocturia.
Benign Prostatic Hyperplasia (BPH)
- Assessment of current status: Stable overall, but slight worsening of nocturia. Patient tolerating Tamsulosin well.
- Plan: Continue Tamsulosin 0.4mg daily. Discussed potential addition of a 5-alpha reductase inhibitor if symptoms worsen significantly. Reassurance regarding PSA level and stability.
- Counselling: Medication adherence, importance of fluid management in the evening, benefits and potential side effects of Tamsulosin. Discussed watchful waiting versus further medical or surgical interventions if symptoms progress.
ORDERS:
Laboratory tests: Repeat PSA in 6 months.
FOLLOW UP:
Review in urology OPD in 6 months with repeat PSA results.
SHORT SUMMARY:
Patient reviewed for follow-up of LUTS secondary to BPH. Remains stable on Tamsulosin, with a slight increase in nocturia. Will continue same treatment and return for PSA result in 6 months.
CHIEF COMPLAINT:
[urological symptoms or reason for consultation — e.g. lower urinary tract symptoms, recurrent UTIs, haematuria, flank pain, erectile dysfunction]
(Only include if explicitly mentioned in transcript or context, else omit section entirely.)
PAST UROLOGICAL HISTORY:
[summary of prior urology consultations, public or private sector labs/imaging, state hospital procedures, known conditions such as history of catheterisation, prostate issues, kidney stones, or previous urological surgeries. Include prior clinician or hospital name and patient’s occupation if mentioned]
(Only include if explicitly mentioned in transcript or context, else omit section entirely.)
HPI TODAY [DD/MM/YYYY]:
[description of any recent changes in urological condition, symptom flare-up, or new concerns since last consultation — e.g. increased frequency, urgency, nocturia, or pain]
[current symptoms or patient confirmation that there are no current symptoms]
[summary of relevant scan or ultrasound (e.g. from district or tertiary hospital) with findings. Include: “I personally reviewed and independently interpreted the scan and concur with findings.”]
[lab results relevant to today’s consultation — e.g. urine dipstick, U&E, PSA, or FBC]
[AUA symptom score, if documented]
[PVR volume post-void residual if done at clinic/hospital]
[PSA density, if available]
(Only include if explicitly mentioned in transcript or context, else omit section entirely.)
PMH, PSH, MEDS, ALLERGIES, SH, and FH:
- [Past medical history: e.g. HIV, hypertension, diabetes, TB, stroke]
- [Past surgical history: e.g. hernia repair, circumcision, prostate biopsy]
- [Medications: ART, chronic medications, over-the-counter or herbal remedies]
- [Allergies: medications, contrast agents, latex]
- [Social history: smoking, alcohol, occupation, housing situation]
- [Family history: urological cancers or renal disease]
(Only include if explicitly mentioned in transcript or context, else omit section entirely.)
PHYSICAL EXAMINATION:
[General appearance and level of consciousness if patient was visibly unwell or in distress]
[Psychiatric findings if applicable — e.g. mood, insight, cooperation]
[Urological exam findings — e.g. DRE findings (size, nodularity, tenderness), palpable bladder, scrotal findings, catheter in situ]
(Only include if explicitly mentioned in transcript or context, else omit section entirely.)
ASSESSMENT AND PLAN:
[Patient’s age and clinical summary — e.g. “68-year-old male presenting with LUTS, stable on treatment”]
(Only include if explicitly mentioned.)
[urological condition name — e.g. BPH, UTI, renal calculi]
- [Assessment of current status — e.g. stable, improving, worsening]
- [Plan — e.g. continue medication, refer for TRUS biopsy, trial of alpha-blocker, surgical listing]
- [Counselling — e.g. medication adherence, lifestyle modifications, risks and benefits of surgery]
(Only include each line if explicitly mentioned.)
[additional urological condition name]
- [Assessment]
- [Plan]
- [Counselling]
(Only include if explicitly mentioned.)
ORDERS:
[laboratory tests (e.g. PSA, U&E, urine MC&S), medications (e.g. Tamsulosin, antibiotics), imaging (e.g. renal ultrasound, KUB X-ray)]
(Only include if explicitly mentioned. If nothing was ordered, write: “No orders.”)
FOLLOW UP:
[follow-up plan, e.g. “Review in urology OPD in 6 weeks,” “Return with PSA results,” “Follow up after imaging”]
(Only include if explicitly mentioned.)
SHORT SUMMARY:
[1–2 sentence summary — e.g. “Patient reviewed for follow-up of LUTS. Remains stable on Tamsulosin; will continue same treatment and return for PSA result.”]
(Only include if explicitly mentioned.)
(Never come up with your own assessment, plan, interventions, evaluation, and plan for continuing care – use only the transcript, contextual notes or clinical note as a reference for the information included in your note. If any information related to a placeholder has not been explicitly mentioned in the transcript, contextual notes or clinical note, you must not state the information has not been explicitly mentioned in your output, just leave the relevant placeholder or omit the section entirely. Use as many lines, paragraphs, or bullet points, depending on the format, as needed to capture all the relevant information from the transcript.)